Tag Archives: ACAD

Thursday’s Midday Movers: ACADIA Pharmaceuticals (ACAD), Peabody Energy Comm (BTU), Microvision (MVIS), Fuelcell Energy (FCEL), 3D Systems (DDD)

So far Thursday, July 22, NASDAQ is up 0.06% and the S&P is up 0.4%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; ACADIA Pharmaceuticals (ACAD – Research Report), Peabody Energy Comm (BTU

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD) and AngioDynamics (NASDAQ: ANGO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on ACADIA Pharmaceuticals (ACAD – Research Report) and AngioDynamics (ANGO – Research Report). ACADIA Pharmaceuticals (ACAD) Raymond James analyst Danielle Brill maintained a Hold rating on

ACADIA Pharmaceuticals (ACAD) Initiated with a Hold at Berenberg Bank

ACADIA Pharmaceuticals (ACAD – Research Report) received a Hold rating and a $29.00 price target from Berenberg Bank analyst Esther Hong today. The company’s shares closed last Wednesday at $26.13. According to TipRanks.com, Hong is a 2-star analyst with an

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD), Catalyst Pharma (NASDAQ: CPRX) and Minerva Neurosciences (NASDAQ: NERV)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on ACADIA Pharmaceuticals (ACAD – Research Report), Catalyst Pharma (CPRX – Research Report) and Minerva Neurosciences (NERV – Research Report). ACADIA Pharmaceuticals (ACAD) In a report

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD) and Bluebird Bio (NASDAQ: BLUE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ACADIA Pharmaceuticals (ACAD – Research Report) and Bluebird Bio (BLUE – Research Report). ACADIA Pharmaceuticals (ACAD) In a report released today, Vamil Divan

Analysts Have Conflicting Sentiments on These Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD) and Constellation Pharmaceuticals (NASDAQ: CNST)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ACADIA Pharmaceuticals (ACAD – Research Report) and Constellation Pharmaceuticals (CNST – Research Report). ACADIA Pharmaceuticals (ACAD) In a report released yesterday, Vamil Divan